Nuon KRX:123840KOSDAQ
뉴온 · Korean news coverage and regulatory filings, organized.
Articles, 24h0
Articles, 7 days0
DART filings, 7 days0
Articles tracked5since Sep 11
In Q2 2026, Nuon reported revenue of ₩13.8bn, down 3.7% year on year, and operating profit of ₩182m. Nuon (뉴온) appeared in 0 Korean news articles and 0 DART filings over the past seven days.
Filing signals Turnaround Screener
Nuon quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩13.8bn | -3.7% | ₩182m margin 1.3% | −₩13.1bn |
| Q1 2026 | ₩13.6bn | +53.1% | −₩2.1bn margin −15.2% | −₩7.2bn |
| Q4 2025 derived | ₩8.0bn | +1374.1% | −₩318m margin −4.0% | −₩14.9bn |
| Q3 2025 | ₩16.9bn | +170.4% | −₩3.8bn margin −22.7% | −₩13.7bn |
| Q2 2025 | ₩14.4bn | +145.8% | −₩3.5bn margin −24.1% | ₩416m |
| Q1 2025 | ₩8.9bn | +113.5% | −₩5.8bn margin −64.7% | −₩10.6bn |
| Q4 2024 derived | ₩541m | -63.0% | −₩5.0bn | −₩24.7bn |
| Q3 2024 | ₩6.3bn | +1237.6% | −₩1.6bn margin −24.9% | −₩955m |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.
Nuon top stories 2 weeks, by number of outlets
No story covered by multiple outlets in the past two weeks.
Latest Nuon news Korean headlines
-
뉴온, 목련꽃봉오리추출물 잇몸 기능성 인정
1 more on this story · 1 outlets
- 뉴온, ‘목련꽃봉오리추출물’ 식약처 기능성 인정…연내 잇몸 건기식 출시이투데이 · Oct 14 09:42
-
Major뉴온, 목련 꽃봉오리추출물 식약처 잇몸 건강 기능성 인정
1 more on this story · 1 outlets
- 뉴온, 목련꽃봉오리추출물 식약처 잇몸 건강 기능성 인정...연내 건기식 출시머니투데이 · Oct 14 10:06